| Application no. and date | 04015299.3 (espacenet) (Federated) (European Patent Register), 20010531 | | Patent/reg. no. and date | DK/EP 1493745, 20120425 | | Publication date | 20050105 | | Priority no. and date | GB 0013407, 20000602 | | EP pub. no. and date |
EP 1493745 20050105 | | Effective date | | | Applicant/owner | AstraZeneca AB,
151 85 Södertälje, SE | | Applicant ref. no. | AST100076 | | Inventor | BOHLIN, Martin, AstraZeneca R & D Södertälje
S-151 85 Södertälje, SE,
LASSEN, Bo, AstraZeneca R & D Södertälje
S-151 85 Södertälje, SE,
Cosgrove, Steve, AstraZeneca R&D Charnwood
Bakewell Road
Loughborough
Leicestershire LE 11 5RH, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/519 (2006.01) , A61P 7/02 (2006.01) , A61P 9/10 (2006.01) , C07D 487/04 (2006.01) | | Title | Ny krystallinsk og amorf form af en triazolo(4,5-D)pyrimidin-forbindelse | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
